Entries by BioSpace

, ,

Allergan Slams Down $250 Million+ for Rights to Merck & Co.’s Migraine Drugs

Dublin, Ireland-based Allergan plc announced today that it inked an agreement to acquire worldwide rights to two of Merck & Co. (MRK)’s small molecule oral calcitonin gene-related peptide (CGRP) receptor antagonists to treat migraine. Allergan Inc. (AGN) will pay $250 million upfront and another $125 upon Hart-Scott-Rodino (HSR) antitrust clearance, and the other $125 million […]

, , ,

Horizon Pharma Goes Hostile With $3 Billion Bid for Depomed

Irish firm Horizon Pharma (HZNP) has made a hostile $3 billion bid for painkiller drugmaker Depomed, Inc. (DEPO), after a series of advances made by Horizon have been decidedly rebuffed since its initial offer in May. Under the terms of the offer, Horizon would payDepomed, Inc. $29.25, which is unchanged from its first May offer, […]

, , , ,

Novo Nordisk A/S Walks Away From GLP-1 Patch Zosano Pharma Inc. Pact

Novo Nordisk (NVO) is terminating its 18 month partnership with Zosano Pharma Corporation to use that company’s micro-needle application to deliver glucagon-like peptide-1 (GLP-1) analogues for the treatment of type 2 diabetes. The termination of the collaboration, which had the potential to generate more than $115 million in revenue, was announced this morning. Novo Nordisk […]

, , , ,

Allergan Forks Over $125 Million+ for Bay Area Medtech Firm Oculeve

Allergan PLC is backing up dry eye treatment drug Restasis by adding another dry eye care treatment to its portfolio with the $125 million-plus acquisition of U.S. –based Oculeve, a development-stage medical device company, the company announced this morning. The acquisition was classified as an all-cash transaction, which includes $125 million in upfront payments and […]

, , , ,

Teva’s DuoResp Spiromax Wins Leading Award For Medical Design Excellence

AMSTERDAM, July 2, 2015 /PRNewswire/ — Teva Pharmaceutical Industries Ltd. today announced that its DuoResp Spiromax® inhaler has won silver at the 2015 Medical Design Excellence Awards (MDEA). The awards recognize significant advances in medical product design that improve the quality of healthcare delivery. DuoResp Spiromax® (budesonide/formoterol fumarate dihydrate) is a new multi-dose dry-powder inhaler […]

, , ,

Johnson & Johnson HIV Vaccine Blocks Virus in 50% of Monkeys

Johnson & Johnson (JNJ) announced positive results for its HIV vaccine trials in monkeys. The study was conducted by researchers at Beth Israel Deaconess Medical Center, Crucell Holland BV (a Janssen Pharmaceutical Company), and several other research collaborators. The study was published in the online edition of Science. “Despite great progress in HIV treatments, HIV […]

, , , ,

Cancer Doc Failed to Report $138,000 Payment From Celgene As Probe Continues

The U.S. Centers for Medicare & Medicaid Services (CMS) yesterday published data indicating that New York University of Rochester professor emeritus John Bennett received $138,986 in compensation from Celgene Corporation (CELG) despite indicating no conflict of interest on a paper published in support of the company’s drug Revlimid.   In May 2014, Bennett and eight […]

, , ,

No Worries, Bayer Snubs Zoetis But Valeant Still Looking

July 2, 2015By Riley McDermid, BioSpace.com Breaking News Sr. Editor Healthcare conglomerate Bayer (BAY) is not in talks to acquire animal health company Zoetis (GZTS), it told an analyst recently, a week after widespread reports linked it and Canadian drugmaker Valeant Pharmaceuticals International, Inc. (VRX) to forthcoming bids for the firm. Sanford Bernstein analyst Ronny […]